Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease
Launched by WILLIAM JENNINGS BRYAN DORN VA MEDICAL CENTER · Apr 29, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Able to consent for participation in a clinical study
- • Able to read and comprehend English
- • Evidence of fatty liver disease on previous liver biopsy, imaging or clinical documentation
- Exclusion Criteria:
- • Pregnant
- • Known decompensated cirrhosis or hepatocellular carcinoma
- • Absence of spleen
- • Documentation of alcohol use disorder or alcohol use greater than 20g/day for women or greater than 30 g/day for men
- • Unable to provide informed consent
About William Jennings Bryan Dorn Va Medical Center
The William Jennings Bryan Dorn VA Medical Center is a leading healthcare facility dedicated to providing comprehensive medical services to veterans. As a prominent sponsor of clinical trials, the center is committed to advancing medical research and improving patient care through innovative studies. With a focus on evidence-based practices, the Dorn VA Medical Center actively engages in research across various disciplines, ensuring that veterans have access to the latest treatment options and therapies. The center prioritizes the health and well-being of its patients while fostering a collaborative environment for researchers and healthcare professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Patients applied
Trial Officials
Nicholas Hoppmann, MD
Principal Investigator
Columbia VA Healthcare System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported